Collplant biotechnologies reports year end financial results for fiscal year 2020

Rehovot, israel, march 26, 2021 /prnewswire/ -- collplant (nasdaq: clgn), a regenerative and aesthetic medicine company, today announced financial results for the full year ended december 31, 2020 and provided an update on the company's business developments. certain metrics, including those expressed on an adjusted basis, are non-gaap measures.

CLGN Ratings Summary

CLGN Quant Ranking